Evidence map›Paper›PMID 29882045›Full record

ArticleJournal of neuro-oncology2018

Evaluation of radiation-related invasion in primary patient-derived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET.

M Wank, D Schilling, J Reindl, B Meyer, J Gempt, S Motov, F Alexander, J J Wilkens, J Schlegel, T E Schmid and 1 more

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Iron Mediates Radiation-Induced Glioblastoma Cell Diffusion.International journal of molecular sciences · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

M WankInstitute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Oberschleißheim, Germany.ORCID http://orcid.org/0000-0001-6353-282X
D SchillingInstitute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Oberschleißheim, Germany.
J ReindlInstitute for Applied Physics and Metrology, Bundeswehr University Munich, Neubiberg, Germany.
B MeyerDepartment of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
J GemptDepartment of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
S MotovDepartment of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
F AlexanderDepartment of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
J J WilkensDepartment of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
J SchlegelDepartment of Neuropathology, Technical University of Munich (TUM), Munich, Germany.
T E SchmidInstitute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Oberschleißheim, Germany.
S E CombsInstitute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Oberschleißheim, Germany. stephanie.combs@tum.de.
TUM Klinikum · DETechnical University of Munich · DEUniversität der Bundeswehr München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGlioblastoma multiforme (GBM) is the most common primary brain tumor and has a very poor overall prognosis. Multimodal treatment is still inefficient and one main reason is the invasive nature of GBM cells, enabling the tumor cells to escape from the treatment area causing tumor progression. This experimental study describes the effect of low- and high-LET irradiation on the invasion of primary GBM cells with a validation in established cell systems.

methodsSeven patient derived primary GBM as well as three established cell lines (LN229, LN18 and U87) were used in this study. Invasion was investigated using Matrigel® coated transwell chambers. Irradiation was performed with low- (X-ray) and high-LET (alpha particles) radiation. The colony formation assay was chosen to determine the corresponding alpha particle dose equivalent to the X-ray dose.

results4 Gy X-ray irradiation increased the invasive potential of six patient derived GBM cells as well as two of the established lines. In contrast, alpha particle irradiation with an equivalent dose of 1.3 Gy did not show any effect on the invasive behavior. The findings were validated with established cell lines.

conclusionOur results show that in contrast to low-LET irradiation high-LET irradiation does not enhance the invasion of established and primary glioblastoma cell lines. We therefore suggest that high-LET irradiation could become an alternative treatment option. To fully exploit the benefits of high-LET irradiation concerning the invasion of GBM further molecular studies should be performed.

Indexed as

X-Ray TherapyAlpha ParticlesBrain NeoplasmsCells, CulturedCell SurvivalDose-Response Relationship, RadiationGlioblastomaHumansNeoplasm InvasivenessBrain tumorGlioblastoma multiformeInvasionIrradiationPrimary cellsSurvival

Identifiers

PMID29882045
OpenAlexW2805829062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.